BR100 Increased By (0.89%)
BR30 Increased By (1.1%)
KSE100 Increased By (0.94%)
KSE30 Increased By (0.89%)
AGHA 6.03 No Change ▼ 0.00 (0%)
BECO 3.83 Decreased By ▼ -0.03 (-0.78%)
BML 60.65 Decreased By ▼ -0.35 (-0.57%)
BOP 28.42 Increased By ▲ 0.33 (1.17%)
CNERGY 11.92 Increased By ▲ 0.18 (1.53%)
CSIL 5.36 Increased By ▲ 0.06 (1.13%)
FCCL 55.75 Increased By ▲ 1.29 (2.37%)
FFL 13.08 Increased By ▲ 0.01 (0.08%)
FNEL 1.14 Increased By ▲ 0.03 (2.7%)
KEL 5.75 Increased By ▲ 0.12 (2.13%)
KOSM 5.37 Increased By ▲ 0.03 (0.56%)
LOTCHEM 23.90 Increased By ▲ 0.07 (0.29%)
MLCF 94.70 Increased By ▲ 1.72 (1.85%)
NBP 165.90 Increased By ▲ 2.70 (1.65%)
NCPL 48.80 Increased By ▲ 0.53 (1.1%)
NPL 49.80 Increased By ▲ 0.09 (0.18%)
OGDC 305.39 Increased By ▲ 1.76 (0.58%)
PACE 9.12 Increased By ▲ 0.15 (1.67%)
PAEL 32.29 Increased By ▲ 0.38 (1.19%)
PIBTL 13.10 Increased By ▲ 0.36 (2.83%)
PPL 214.50 Increased By ▲ 1.59 (0.75%)
PRL 85.65 Increased By ▲ 1.31 (1.55%)
PTC 45.50 Increased By ▲ 0.51 (1.13%)
SSGC 22.89 Increased By ▲ 0.06 (0.26%)
TBL 8.95 Increased By ▲ 0.07 (0.79%)
TELE 6.56 Increased By ▲ 0.06 (0.92%)
TPL 24.90 Increased By ▲ 0.64 (2.64%)
TPLP 12.41 Increased By ▲ 0.42 (3.5%)
TREET 23.24 Increased By ▲ 0.10 (0.43%)
TRG 52.10 Increased By ▲ 0.63 (1.22%)
Markets

Latam risk assets gain on vaccine-led recovery bets

  • Brazil stocks hit record intraday high; overall debt falls.
  • UK approves COVID-19 vaccine developed by AstraZeneca.
  • COVID-19 cases surge across Latin America.
Published Updated
By

Most Latin American currencies rose on Wednesday, tracking broad dollar weakness and optimism around vaccine developments, while Brazil's benchmark stock index jumped as improving economic readings offset fears of surging coronavirus cases.

Chile's peso and Colombia's peso rose in early trade, while Brazilian stocks hit a record intraday high on improving public finances, as investor hopes for a quick economic revival were reinforced by encouraging vaccine news.

The United Kingdom approved the coronavirus vaccine developed by the University of Oxford and AstraZeneca, which has an agreement with the Brazilian government to supply doses to the country.

"Risk sentiment remains buoyant, with vaccine roll-out hopes providing confidence despite growing COVID-19 case numbers," said Stephen Innes, chief global market strategist at Axi.

Brazil posted a $3.5 billion public sector budget deficit in November as the government maintained spending to tackle the COVID-19 pandemic, but as a share of the economy the deficit steadied and overall debt fell.

Brazilian President Jair Bolsonaro said in a video broadcast that Brazil had reached its debt limit while dealing with the impact of the COVID-19 pandemic, and called for a return to normality in the country.

The currency of oil-exporting nation Mexico dropped 0.2% as a surge in coronavirus-related deaths and fresh lockdowns offset gains in crude prices.

More than a quarter of Latin America's deaths have been in Mexico, which, like Brazil, has struggled with a new wave of infections, with rising hospitalizations forcing Mexico City and four states into semi-lockdowns.

The Chilean peso rose 0.6% as the country looked to approve AstraZeneca's vaccine candidate within "weeks or even days" after it receives approval from European or American regulators.

Latin American currencies have lost nearly 13.2% this year, and have severely underperformed their broader emerging market peers.

MSCI's index of regional stocks rose 0.2%.

Comments

Comments are closed for this article.